2024-01-012024-12-312024-12-31false08000749INTEGRATED MEDICAL CENTRE LTD2025-03-2186900falseiso4217:GBPxbrli:pure080007492024-01-01080007492024-12-31080007492024-01-012024-12-31080007492023-01-01080007492023-12-31080007492023-01-012023-12-3108000749bus:SmallEntities2024-01-012024-12-3108000749bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3108000749bus:FullAccounts2024-01-012024-12-3108000749bus:PrivateLimitedCompanyLtd2024-01-012024-12-3108000749core:WithinOneYear2024-12-3108000749core:AfterOneYear2024-12-3108000749core:WithinOneYear2023-12-3108000749core:AfterOneYear2023-12-3108000749core:ShareCapital2024-12-3108000749core:SharePremium2024-12-3108000749core:RevaluationReserve2024-12-3108000749core:OtherReservesSubtotal2024-12-3108000749core:RetainedEarningsAccumulatedLosses2024-12-3108000749core:ShareCapital2023-12-3108000749core:SharePremium2023-12-3108000749core:RevaluationReserve2023-12-3108000749core:OtherReservesSubtotal2023-12-3108000749core:RetainedEarningsAccumulatedLosses2023-12-3108000749core:LandBuildings2024-12-3108000749core:PlantMachinery2024-12-3108000749core:Vehicles2024-12-3108000749core:FurnitureFittings2024-12-3108000749core:OfficeEquipment2024-12-3108000749core:NetGoodwill2024-12-3108000749core:IntangibleAssetsOtherThanGoodwill2024-12-3108000749core:ListedExchangeTraded2024-12-3108000749core:UnlistedNon-exchangeTraded2024-12-3108000749core:LandBuildings2023-12-3108000749core:PlantMachinery2023-12-3108000749core:Vehicles2023-12-3108000749core:FurnitureFittings2023-12-3108000749core:OfficeEquipment2023-12-3108000749core:NetGoodwill2023-12-3108000749core:IntangibleAssetsOtherThanGoodwill2023-12-3108000749core:ListedExchangeTraded2023-12-3108000749core:UnlistedNon-exchangeTraded2023-12-3108000749core:LandBuildings2024-01-012024-12-3108000749core:PlantMachinery2024-01-012024-12-3108000749core:Vehicles2024-01-012024-12-3108000749core:FurnitureFittings2024-01-012024-12-3108000749core:OfficeEquipment2024-01-012024-12-3108000749core:NetGoodwill2024-01-012024-12-3108000749core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3108000749core:ListedExchangeTraded2024-01-012024-12-3108000749core:UnlistedNon-exchangeTraded2024-01-012024-12-3108000749core:MoreThanFiveYears2024-01-012024-12-3108000749core:Non-currentFinancialInstruments2024-12-3108000749core:Non-currentFinancialInstruments2023-12-3108000749dpl:CostSales2024-01-012024-12-3108000749dpl:DistributionCosts2024-01-012024-12-3108000749core:LandBuildings2024-01-012024-12-3108000749core:PlantMachinery2024-01-012024-12-3108000749core:Vehicles2024-01-012024-12-3108000749core:FurnitureFittings2024-01-012024-12-3108000749core:OfficeEquipment2024-01-012024-12-3108000749dpl:AdministrativeExpenses2024-01-012024-12-3108000749core:NetGoodwill2024-01-012024-12-3108000749core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3108000749dpl:GroupUndertakings2024-01-012024-12-3108000749dpl:ParticipatingInterests2024-01-012024-12-3108000749dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3108000749core:ListedExchangeTraded2024-01-012024-12-3108000749dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3108000749core:UnlistedNon-exchangeTraded2024-01-012024-12-3108000749dpl:CostSales2023-01-012023-12-3108000749dpl:DistributionCosts2023-01-012023-12-3108000749core:LandBuildings2023-01-012023-12-3108000749core:PlantMachinery2023-01-012023-12-3108000749core:Vehicles2023-01-012023-12-3108000749core:FurnitureFittings2023-01-012023-12-3108000749core:OfficeEquipment2023-01-012023-12-3108000749dpl:AdministrativeExpenses2023-01-012023-12-3108000749core:NetGoodwill2023-01-012023-12-3108000749core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3108000749dpl:GroupUndertakings2023-01-012023-12-3108000749dpl:ParticipatingInterests2023-01-012023-12-3108000749dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3108000749core:ListedExchangeTraded2023-01-012023-12-3108000749dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3108000749core:UnlistedNon-exchangeTraded2023-01-012023-12-3108000749core:NetGoodwill2024-12-3108000749core:IntangibleAssetsOtherThanGoodwill2024-12-3108000749core:LandBuildings2024-12-3108000749core:PlantMachinery2024-12-3108000749core:Vehicles2024-12-3108000749core:FurnitureFittings2024-12-3108000749core:OfficeEquipment2024-12-3108000749core:AfterOneYear2024-12-3108000749core:WithinOneYear2024-12-3108000749core:ListedExchangeTraded2024-12-3108000749core:UnlistedNon-exchangeTraded2024-12-3108000749core:ShareCapital2024-12-3108000749core:SharePremium2024-12-3108000749core:RevaluationReserve2024-12-3108000749core:OtherReservesSubtotal2024-12-3108000749core:RetainedEarningsAccumulatedLosses2024-12-3108000749core:NetGoodwill2023-12-3108000749core:IntangibleAssetsOtherThanGoodwill2023-12-3108000749core:LandBuildings2023-12-3108000749core:PlantMachinery2023-12-3108000749core:Vehicles2023-12-3108000749core:FurnitureFittings2023-12-3108000749core:OfficeEquipment2023-12-3108000749core:AfterOneYear2023-12-3108000749core:WithinOneYear2023-12-3108000749core:ListedExchangeTraded2023-12-3108000749core:UnlistedNon-exchangeTraded2023-12-3108000749core:ShareCapital2023-12-3108000749core:SharePremium2023-12-3108000749core:RevaluationReserve2023-12-3108000749core:OtherReservesSubtotal2023-12-3108000749core:RetainedEarningsAccumulatedLosses2023-12-3108000749core:NetGoodwill2023-01-0108000749core:IntangibleAssetsOtherThanGoodwill2023-01-0108000749core:LandBuildings2023-01-0108000749core:PlantMachinery2023-01-0108000749core:Vehicles2023-01-0108000749core:FurnitureFittings2023-01-0108000749core:OfficeEquipment2023-01-0108000749core:AfterOneYear2023-01-0108000749core:WithinOneYear2023-01-0108000749core:ListedExchangeTraded2023-01-0108000749core:UnlistedNon-exchangeTraded2023-01-0108000749core:ShareCapital2023-01-0108000749core:SharePremium2023-01-0108000749core:RevaluationReserve2023-01-0108000749core:OtherReservesSubtotal2023-01-0108000749core:RetainedEarningsAccumulatedLosses2023-01-0108000749core:AfterOneYear2024-01-012024-12-3108000749core:WithinOneYear2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3108000749core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3108000749core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3108000749core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3108000749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3108000749core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3108000749core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3108000749core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3108000749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3108000749core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3108000749core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3108000749core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3108000749core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3108000749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3108000749core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3108000749core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3108000749core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3108000749core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3108000749core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3108000749bus:Director12024-01-012024-12-3108000749bus:Director22024-01-012024-12-31

INTEGRATED MEDICAL CENTRE LTD

Registered Number
08000749
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

INTEGRATED MEDICAL CENTRE LTD
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

ALI, Imran
ALI, Sheikha

Registered Address

121 Crawford Street
London
W1U 6BE

Registered Number

08000749 (England and Wales)
INTEGRATED MEDICAL CENTRE LTD
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors3-22,765
Cash at bank and on hand-30,581
-53,346
Creditors amounts falling due within one year4-(36,636)
Net current assets (liabilities)-16,710
Total assets less current liabilities-16,710
Creditors amounts falling due after one year5-(9,213)
Net assets-7,497
Capital and reserves
Called up share capital200200
Profit and loss account(200)7,297
Shareholders' funds-7,497
The financial statements were approved and authorised for issue by the Board of Directors on 21 March 2025, and are signed on its behalf by:
ALI, Imran
Director
Registered Company No. 08000749
INTEGRATED MEDICAL CENTRE LTD
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Financial instruments
The company has elected to apply the provisions of Section 11'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Basic financial liabilities Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20242023
Average number of employees during the year22
3.Debtors: amounts due after one year
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables-753
Bank borrowings and overdrafts-1,825
Amounts owed to related parties-8,500
Accrued liabilities and deferred income-25,558
Total-36,636
5.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts-9,213
Total-9,213